Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
United States
2025 Rank: 110416
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 520 out of 122662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110416 | 118717 |
| Total Cites | 603 | 629 |
| H-index | 9 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 178 | 178 |
| Total Cites to Single+First+Last Authored Papers | 352 | 359 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 416 | 435 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.45 |
| Self-Citation Percentage |
4.13%
|
|
Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
United States
2024 Rank: 84605
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 399 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84605 | 95955 |
| Total Cites | 643 | 669 |
| H-index | 10 | 10 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 22 | 23 |
| Number of Single+First+Last Authored Papers | 177 | 177 |
| Total Cites to Single+First+Last Authored Papers | 355 | 360 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 433 | 444 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.51 |
| Self-Citation Percentage |
3.89%
|
|
Brechbiel, Martin W.
Cancer Biotherapy and Radiopharmaceuticals,
Italy
2023 Rank: 57639
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 254 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57639 | 67258 |
| Total Cites | 809 | 841 |
| H-index | 11 | 11 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 33 | 33 |
| Number of Single+First+Last Authored Papers | 176 | 176 |
| Total Cites to Single+First+Last Authored Papers | 423 | 427 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 502 | 517 |
| Ratio of Total Citations to Distinct Citing Papers | 1.61 | 1.63 |
| Self-Citation Percentage |
3.80%
|
|
Brechbiel, Martin W.
National Cancer Institute (NCI),
United States
2021 Rank: 55782
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 266 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55782 | 65220 |
| Total Cites | 1202 | 1275 |
| H-index | 14 | 14 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 26 | 26 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 39 | 39 |
| Number of Single+First+Last Authored Papers | 174 | 174 |
| Total Cites to Single+First+Last Authored Papers | 615 | 629 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 793 | 826 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.54 |
| Self-Citation Percentage |
5.73%
|
|